Neutrogena, Aveeno, and Rogaine, part of the Kenvue portfolio, debuts new science, innovative products, and 20 research abstracts.

This will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, March 27–31.

At AAD 2026, presentations and onsite experiences will highlight advances addressing concerns from fine lines to daily sun protection. 

Dr. Michelle Bateson, Vice President and Head of North America Research and Development at Kenvue, said, 

“We are contributing to an industry-wide reimagining of the beauty aisle by creating accessible, effective formulas that are backed by science and co-designed by dermatologists and trichologists. Healthcare providers are the most trusted source for personal care advicei, and our research demonstrates how blending clinical data with cultural relevance to address everyday skin health and beauty challenges is the key to forging trust and connection with healthcare providers and consumers.”

In collaboration with industry experts, the brands will share clinical research that evaluates current formulas and introduces new solutions designed to hydrate skin, support healthy aging, maintain hair health, and strengthen protection against UV exposure.

Key areas of focus the company will spotlight include:

• Healthy Aging Skincare Innovations & Vitamin C Research for UV–Induced Damage
• Skin Hydration Research for Sensitive Skin: Hydro Boost, Oat Formulas & Barrier Support
• Clinical Acne Solutions with Skin–Barrier–Safe Ingredients
• BEMT Sunscreen Research, UV Filter Innovation, & Daily Protection Gaps
• Clinical Education, Resident Training, & Dermatology Resources

Read Next

Shareholders Approve Kimberly-Clark’s Acquisition of Kenvue